Home > Category > Signaling Pathways > Immunology & Inflammation > CTLA-4 > Tremelimumab (anti-CTLA-4)

Tremelimumab (anti-CTLA-4)

ChemLeader 95+%
Catalog No:CLA1189 CAS No.:745013-59-6 MDLNo: Formula: MW:
Size Availability Price(USD) VIP Price (USD) Quantity
1 mg 3-5days $530.00 Visible after login
- +
5 mg 3-5days $1200.00 Visible after login
- +
10 mg 3-5days $1900.00 Visible after login
- +
50 mg 3-5days $6000.00 Visible after login
- +
100 mg 3-5days $12000.00 Visible after login
- +

Chemical safety data sheet(MSDS)

Download MSDS
  • Product Overview
  • Related documents
  • Product details
  • Related literature
Product Overview
Product Name Tremelimumab (anti-CTLA-4)
CAS745013-59-6
Storage conditionStore at 2 to 8 °C for 1-2 weeks. Store at -20 °C for 12 months. Store at -80 °C for long term storage. Use a manual defrost freezer and avoid repeated freeze-thaw cycles, away from light.
Product details

Tremelimumab is a cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) blocking antibody.Tremelimumab is often used in combination with Durvalumab for the treatment of solid cancers such as hepatocellular carcinoma and lung cancer.

Related literature
Sorry, there is no relevant literature
Related
Sorry, no related items
Service
ChemLeader
021-58180488
Online service time: 9:00-18:00 on weekdays